Tifacogin

DB06437InvestigationalSmall molecule

Investigated for use/treatment in sepsis and septicemia and pneumonia.

Primary indication
Investigated for use/treatment in sepsis and septicemia and pneumonia.Curator reviewed
Code names
SC-59735

Resolves to

Compound
UNII415ZN8YW42CAS148883-56-1
Targets
P10646TFPI

What you can answer from here — as of February 04, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Tifacogin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In